CHROMAgar™ LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients-a multicentre study approach, 2021-2022. [PDF]
Bender JK +27 more
europepmc +1 more source
Global dissemination of optrA-mediated linezolid resistance in enterococci. [PDF]
Beh JQ, Howden BP, Webb JR, Connor CH.
europepmc +1 more source
Genomics to understand the global landscape of linezolid resistance in <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i>. [PDF]
Beh JQ +9 more
europepmc +1 more source
Genomic epidemiology and characterization of <i>Staphylococcus aureus</i> isolates from raw milk in Jilin, China: evidence of contamination with <i>optrA</i>-positive, <i>cfrA</i>-positive, and <i>poxtA</i>-positive strains and human-livestock transmission. [PDF]
Liu Q, Ma P, Gu Q, Yang W, Li C.
europepmc +1 more source
Molecular Characteristics and Antimicrobial Resistance of Linezolid-Resistant <i>Staphylococcus aureus</i> in Osteoarticular Infections: A 11-Year Study From a Hospital in Xi'an. [PDF]
Zhou S +7 more
europepmc +1 more source
Global epidemiological insights on the antimicrobial resistance of <i>Enterococcus faecium</i> and a genomic analysis framework. [PDF]
Lee K, Jang YH, Park K, Sung H, Kim MN.
europepmc +1 more source
Genomic and clinical characterization of linezolid resistance in Enterococcus species from cancer patients in China. [PDF]
Wang Q +5 more
europepmc +1 more source
Hybrid Antibiotics Targeting the Bacterial Ribosome. [PDF]
Yeon SK +9 more
europepmc +1 more source
Resistance mechanisms and tedizolid susceptibility in clinical isolates of linezolid-resistant bacteria in Japan. [PDF]
Shoji R +9 more
europepmc +1 more source

